172 related articles for article (PubMed ID: 38593151)
21. Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells.
Tseng WL; Chou SJ; Chiang HC; Wang ML; Chien CS; Chen KH; Leu HB; Wang CY; Chang YL; Liu YY; Jong YJ; Lin SZ; Chiou SH; Lin SJ; Yu WC
Cell Transplant; 2017 Mar; 26(3):513-527. PubMed ID: 27938475
[TBL] [Abstract][Full Text] [Related]
22. A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease.
Talbot A; Nicholls K; Fletcher JM; Fuller M
Mol Genet Metab; 2017 Sep; 122(1-2):121-125. PubMed ID: 28847675
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
[TBL] [Abstract][Full Text] [Related]
24. Endothelial Cell Dysfunction and Hypoxia as Potential Mediators of Pain in Fabry Disease: A Human-Murine Translational Approach.
Klug K; Spitzel M; Hans C; Klein A; Schottmann NM; Erbacher C; Üçeyler N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895103
[TBL] [Abstract][Full Text] [Related]
25. Screening for Fabry disease in a series of Parkinson's disease patients and literature review.
Perillo S; Palmieri GR; Del Moral MO; De Michele G; Giglio A; Cuomo N; Pane C; Bauer P; De Michele G; De Rosa A
Neurol Sci; 2023 Apr; 44(4):1235-1241. PubMed ID: 36547780
[TBL] [Abstract][Full Text] [Related]
26. Beneficial screening of Fabry disease in patients with hypohidrosis.
Nagai-Sangawa M; Fukunaga A; Takeuchi C; Nishiyama S; Horikawa T; Nagano C; Nozu K; Fujii H; Nishigori C
J Dermatol; 2022 Feb; 49(2):308-312. PubMed ID: 34796992
[TBL] [Abstract][Full Text] [Related]
27. Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblasts.
Fuller M; Mellett N; Hein LK; Brooks DA; Meikle PJ
Mol Genet Metab; 2015 Feb; 114(2):268-73. PubMed ID: 25468650
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.
Valbuena C; Leitão D; Carneiro F; Oliveira JP
Virchows Arch; 2012 Feb; 460(2):211-21. PubMed ID: 22205110
[TBL] [Abstract][Full Text] [Related]
29. Characterization of small fiber pathology in a mouse model of Fabry disease.
Hofmann L; Hose D; Grießhammer A; Blum R; Döring F; Dib-Hajj S; Waxman S; Sommer C; Wischmeyer E; Üçeyler N
Elife; 2018 Oct; 7():. PubMed ID: 30328411
[TBL] [Abstract][Full Text] [Related]
30. Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.
Schiffmann R; Forni S; Swift C; Brignol N; Wu X; Lockhart DJ; Blankenship D; Wang X; Grayburn PA; Taylor MR; Lowes BD; Fuller M; Benjamin ER; Sweetman L
J Am Heart Assoc; 2014 Feb; 3(1):e000394. PubMed ID: 24496231
[TBL] [Abstract][Full Text] [Related]
31. Ion channels and pain in Fabry disease.
Weissmann C; Albanese AA; Contreras NE; Gobetto MN; Castellanos LCS; Uchitel OD
Mol Pain; 2021; 17():17448069211033172. PubMed ID: 34284652
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.
Oder D; Liu D; Üçeyler N; Sommer C; Hu K; Salinger T; Müntze J; Petritsch B; Ertl G; Wanner C; Nordbeck P; Weidemann F
Medicine (Baltimore); 2018 May; 97(21):e10669. PubMed ID: 29794742
[TBL] [Abstract][Full Text] [Related]
33. Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.
Young-Gqamana B; Brignol N; Chang HH; Khanna R; Soska R; Fuller M; Sitaraman SA; Germain DP; Giugliani R; Hughes DA; Mehta A; Nicholls K; Boudes P; Lockhart DJ; Valenzano KJ; Benjamin ER
PLoS One; 2013; 8(3):e57631. PubMed ID: 23472096
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Intermediate-Conductance Calcium-Activated K Channel (KCa3.1) and Fibroblast Mitogenesis by α-Linolenic Acid and Alterations of Channel Expression in the Lysosomal Storage Disorders, Fabry Disease, and Niemann Pick C.
Oliván-Viguera A; Lozano-Gerona J; López de Frutos L; Cebolla JJ; Irún P; Abarca-Lachen E; García-Malinis AJ; García-Otín ÁL; Gilaberte Y; Giraldo P; Köhler R
Front Physiol; 2017; 8():39. PubMed ID: 28197106
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the GLA gene in Mexican families with Fabry disease.
Gutiérrez-Amavizca BE; Gal A; Ortíz-Orozco R; Orth U; Prado Montes De Oca E; Gutiérrez-Amavizca JP; Figuera LE
J Genet; 2017 Mar; 96(1):161-164. PubMed ID: 28360401
[TBL] [Abstract][Full Text] [Related]
36. Case study on the pathophysiology of Fabry disease: abnormalities of cellular membranes can be reversed by substrate reduction
Brogden G; Shammas H; Maalouf K; Naim SL; Wetzel G; Amiri M; von Köckritz-Blickwede M; Das AM; Naim HY
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28351893
[TBL] [Abstract][Full Text] [Related]
37.
Breyer M; Grüner J; Klein A; Finke L; Klug K; Sauer M; Üçeyler N
Mol Genet Metab Rep; 2024 Mar; 38():101029. PubMed ID: 38469097
[TBL] [Abstract][Full Text] [Related]
38. Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis.
van der Tol L; Svarstad E; Ortiz A; Tøndel C; Oliveira JP; Vogt L; Waldek S; Hughes DA; Lachmann RH; Terryn W; Hollak CE; Florquin S; van den Bergh Weerman MA; Wanner C; West ML; Biegstraaten M; Linthorst GE
Mol Genet Metab; 2015 Feb; 114(2):242-7. PubMed ID: 25187469
[TBL] [Abstract][Full Text] [Related]
39. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study.
Yılmaz M; Uçar SK; Aşçı G; Canda E; Tan FA; Hoşcoşkun C; Çoker M; Töz H
Transplant Proc; 2017 Apr; 49(3):420-424. PubMed ID: 28340804
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.
Tuttolomondo A; Simonetta I; Riolo R; Todaro F; Di Chiara T; Miceli S; Pinto A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
